(MENAFN- Straits Research)
Human Genetics Market Size & Growth Analysis
The global human genetics market size was valued at USD 34.41 billion in 2025 and is projected to grow from USD 37.93 billion in 2026 to USD 82.61 billion by 2034, registering a CAGR of 10.22% during the forecast period from 2026 to 2034. Asia Pacific dominated the human genetics market with a market share of 38.6% in 2025.
Human genetics is the branch of science that studies genes, heredity, and genetic variation in humans. It helps identify inherited disorders, supports disease diagnosis, enables genetic testing, and advances precision medicine. Growing demand for personalized healthcare, genomic research, and early disease detection is driving the growth of the human genetics market.
Human Genetics Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 34.41 Billion
2026 Market Size: USD 37.93 Billion
2034 Projected Market Size: USD 82.61 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 10.22%
Regional Insights
Largest Regional Market (2025): Asia-Pacific
Asia-Pacific Market Share (2025): 38.6%
Fastest-Growing Region: North America
North America CAGR (2026–2034): 9.18%
Segment Insights
By Type
Leading Segment: Molecular Genetics
Market Share in 2025: 39.6%
By End-Users
Fastest-growing segment: Research Center
CAGR: 8.76% (2026-2034)
Download a Free Sample To learn more about this report,
Human Genetics Market Trends
Growing Adoption of Genomic Sequencing and Precision Medicine
The human genetics market trends are increasingly driven by the rapid adoption of next-generation sequencing (NGS), whole-genome sequencing, and precision medicine across healthcare systems. Hospitals, diagnostic laboratories, and research institutions are using advanced genetic testing to improve the diagnosis of inherited disorders, rare diseases, and cancer while enabling personalized treatment strategies. Falling sequencing costs, advances in bioinformatics, and greater integration of artificial intelligence are improving the speed and accuracy of genetic data analysis. Governments are also expanding national genomics initiatives and newborn screening programs, further supporting the growth of the human genetics market.
For instance, in February 2025, Foundation Medicine partnered with Fulgent Genetics to launch FoundationOne® Germline and FoundationOne® Germline More in the United States. The new hereditary cancer tests help identify inherited genetic variants and strengthen precision oncology by combining comprehensive genomic profiling with germline testing.
Increasing Expansion of AI-Driven Genetic Testing Solutions
Another important human genetics market trend is the growing integration of artificial intelligence into genetic testing and clinical decision-making. AI-powered platforms are improving variant interpretation, accelerating disease risk assessment, and enabling faster clinical reporting. Strategic collaborations between healthcare technology companies and genomics providers are expanding access to genetic screening while improving early disease detection. These innovations are helping healthcare providers deliver more personalized and data-driven care across multiple therapeutic areas.
For example, in February 2025, Ubie partnered with Nucleus Genomics to integrate AI-powered symptom assessment with comprehensive DNA sequencing, enabling earlier identification of inherited diseases and improving access to personalized genetic testing services.
Human Genetics Market Dynamics
Market Drivers
Increasing Prevalence of Genetic and Rare Diseases
The human genetics market is being driven by the growing need for accurate diagnosis of inherited disorders, rare diseases, and genetically influenced conditions. Many patients with rare or hereditary diseases experience delayed or inconclusive diagnoses, increasing demand for genomic testing that can identify underlying genetic variants. Greater awareness among healthcare professionals, improvements in genetic screening technologies, and the integration of genomic testing into clinical diagnostics are encouraging broader adoption. Expanding newborn screening and hereditary disease testing programs are also contributing to the increasing use of genetic testing across healthcare systems.
For instance, in 2025, healthcare providers and diagnostic laboratories continued expanding genetic screening and testing programs to improve the identification of inherited and rare diseases.
Market Restraints
High Cost of Advanced Genetic Testing and Data Privacy Concerns
The human genetics market faces restraints due to the high cost of advanced genomic sequencing, limited reimbursement in several countries, and concerns regarding genetic data privacy. The complexity of interpreting genomic information also requires skilled professionals and specialized bioinformatics infrastructure, limiting adoption in resource-constrained healthcare systems. Ethical concerns related to genetic data storage and sharing continue to pose additional challenges.
For instance, healthcare providers and regulatory authorities continue to strengthen policies for genomic data protection and patient privacy while expanding access to genetic testing services.
Market Opportunities
Expansion of Direct-to-Consumer and Preventive Genetic Testing
The growing consumer interest in preventive healthcare and personalized health information is creating new opportunities for the human genetics market. Direct-to-consumer genetic testing is expanding beyond ancestry analysis toward health-risk assessment, carrier screening, pharmacogenomics, and wellness applications. Increasing awareness of inherited disease risks and the availability of home-based sample collection are making genetic testing more accessible to consumers. In addition, partnerships between genetic testing companies, healthcare providers, and digital health platforms can expand testing access and support earlier identification of potential health risks.
For instance, in 2025, genetic testing providers continued expanding consumer-focused screening and digital health partnerships, supporting broader access to preventive and personalized genetic testing.
Market Challenges
Shortage of Skilled Genetics Professionals and Complex Data Interpretation
One of the major challenges facing the human genetics market is the shortage of trained genetic counselors, molecular geneticists, and bioinformatics experts needed to interpret increasingly complex genomic data. Variations in testing standards, inconsistent access to genomic services, and the growing volume of sequencing data further complicate clinical decision-making. Ensuring accurate interpretation while maintaining regulatory compliance remains a significant challenge for healthcare providers and testing laboratories.
For instance, in 2025, healthcare organizations continued investing in AI-assisted genomic interpretation platforms and workforce training programs to improve diagnostic accuracy and address the growing demand for genetic testing services.
Human Genetics Market Segmentation Analysis
By Type
Molecular Genetics Segment Dominated the Market with 39.6% Share in 2025
The molecular genetics segment dominated the human genetics market with a 39.6% market share in 2025, accounting for USD 13.63 billion, and is projected to grow at a CAGR of 9.04% during the forecast period. The segment's dominance is driven by the increasing use of molecular diagnostic techniques for identifying inherited disorders, cancer-related mutations, and rare genetic diseases. Growing adoption of next-generation sequencing (NGS), polymerase chain reaction (PCR), and precision medicine continues to strengthen the segment's leading position.
The cytogenetics, prenatal genetics, and symptom genetics segments also contribute significantly to the human genetics market. Rising demand for prenatal screening, chromosomal analysis, and genetic disease diagnosis continues to support the adoption of these testing methods across clinical and research applications.
Request Customization to receive a tailored report.
By End-Users
Research Center Segment is Projected to Register the Fastest Growth at a CAGR of 8.76%
The research center segment is projected to register the fastest CAGR of 8.76% during 2026–2034. The segment accounted for 36.7% of the market, valued at USD 12.63 billion in 2025. Growth is driven by increasing investments in genomics research, expanding government funding, and rising collaborations between academic institutions and biotechnology companies. The growing focus on precision medicine, gene discovery, and advanced genomic technologies is further accelerating segment growth.
The hospital and forensic laboratories segments continue to contribute significantly to the human genetics market. Hospitals remain the largest end-user due to the widespread use of genetic testing for disease diagnosis and personalized treatment, while forensic laboratories continue to adopt genetic analysis for criminal investigations, identity verification, and legal applications.
Speak to an Analyst to discuss market opportunities.
Human Genetics Market Regional Analysis
Asia Pacific Human Genetics Market Analysis
Asia Pacific dominated the human genetics market with a 38.6% share in 2025, accounting for USD 13.28 billion, and is projected to grow at a CAGR of 8.42% during the forecast period. Growth is driven by increasing investments in genomics research, expanding healthcare infrastructure, rising adoption of genetic testing, and growing government support for precision medicine initiatives. The rapid expansion of biotechnology and genomic sequencing capabilities continues to strengthen regional market growth.
Japan Human Genetics Market Insights
Japan's market generated USD 3.05 billion in 2025. Increasing investments in precision medicine, expanding genomic research, growing adoption of next-generation sequencing technologies, and strong government support for healthcare innovation continue to drive market growth.
China Human Genetics Market Insights
China's market accounted for USD 6.90 billion in 2025, representing the largest share within Asia Pacific. Rising government investments in genomics, expanding genetic testing services, increasing biotechnology research, and growing demand for personalized medicine continue to support market expansion.
Unlock Regional Insights to access country-level data, & regional trends.
North America Human Genetics Market Analysis
North America accounted for 31.4% of the human genetics market, reaching USD 10.80 billion in 2025, and is expected to register a CAGR of 9.18% during the forecast period. The regional market is driven by advanced genomic research infrastructure, widespread adoption of precision medicine, increasing healthcare expenditure, and the strong presence of leading biotechnology and genetic testing companies.
United States Human Genetics Market Insights
The U.S. market was valued at USD 9.18 billion in 2025, making it the largest contributor in North America. Strong investments in genomic sequencing, increasing demand for hereditary disease testing, expanding precision medicine programs, and continuous innovation in molecular diagnostics continue to drive market growth.
Canada Human Genetics Market Insights
Canada's market reached USD 1.62 billion in 2025. Growing government support for genomic research, increasing adoption of genetic testing, expanding research collaborations, and rising awareness of personalized healthcare continue to support steady market expansion.
Europe Human Genetics Market Analysis
Europe held 20.7% of the human genetics market, valued at USD 7.12 billion in 2025, and is projected to grow at a CAGR of 7.96% during the forecast period. Increasing investments in genetic research, expanding rare disease screening programs, supportive healthcare policies, and growing adoption of advanced molecular diagnostics continue to accelerate regional market growth.
United Kingdom Human Genetics Market Insights
The U.K. market was valued at USD 1.71 billion in 2025. National genome sequencing initiatives, increasing investments in precision medicine, and expanding genetic testing services continue to support market growth.
Germany Human Genetics Market Insights
Germany's market accounted for USD 2.14 billion in 2025. Strong biotechnology capabilities, increasing demand for molecular diagnostics, expanding genomic research, and growing healthcare investments continue to support market expansion.
Middle East & Africa Human Genetics Market Analysis
Middle East & Africa accounted for 3.9% of the human genetics market, totaling USD 1.34 billion in 2025, and is anticipated to grow at a CAGR of 6.84% during the forecast period. Increasing investments in healthcare infrastructure, growing awareness of genetic disorders, expanding diagnostic services, and rising government initiatives supporting genomic medicine continue to drive regional market growth.
UAE Human Genetics Market Insights
The UAE market was valued at USD 0.31 billion in 2025. Growing investments in genomic medicine, expanding precision healthcare initiatives, and increasing adoption of advanced genetic testing technologies continue to support market growth.
Africa Human Genetics Market Insights
Africa's market reached USD 1.03 billion in 2025. Improving healthcare infrastructure, expanding genetic research programs, increasing awareness of inherited diseases, and growing international collaborations continue to create long-term growth opportunities across the region.
List of Key and Emerging Players in Human Genetics Market
Myriad Genetics
QIAGEN
Agilent Technologies
Thermo Fisher Scientific
Illumina
Promega
LabCorp
GE Healthcare
Bio-Rad Laboratories
Bode Technology
Orchid Cellmark
LGS Forensic,
23andMe
Key Industry Developments
June 2026: Tempus AI acquired Deep 6 AI, expanding its AI-powered clinical trial matching and precision medicine capabilities to strengthen genomic research and human genetics applications.
March 2026: Illumina launched the MiSeq i100 Series sequencing systems in additional global markets, expanding access to next-generation sequencing for clinical genetics and human genomics research.
September 2025: QIAGEN completed the acquisition of Genoox, integrating AI-powered genomic interpretation with its molecular testing portfolio to enhance clinical genetics and precision medicine workflows.
May 2025: PacBio partnered with the University of Washington to expand the use of HiFi long-read sequencing for large-scale human genetics research, supporting improved identification of complex genetic variants.
Report Scope
Comments
No comment